MBX Biosciences, Inc. (MBX) Financial Statements

Comprehensive financial analysis for MBX including key ratios, revenue trends, profitability metrics, and analyst recommendations. Get detailed MBX financial performance analysis and investment insights.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio (TTM):4.30

Forward P/E:-10.94

EPS (TTM):$7.71

Enterprise Value:$1.10B

Profitability Ratios

Profit Margin:N/A

Return on Equity:-24.43%

Return on Assets:-16.64%

Operating Margin:N/A

Financial Health

Current Ratio:32.95

Quick Ratio:32.60

Debt to Equity:0.16

Beta (5Y):N/A

Revenue and Profit Trends

Growth Metrics

Performance Metrics

Return on Equity

-24.43%

Return on Assets

-16.64%

5-Year Revenue & Net Income

Year	Revenue	Revenue YoY	Net Income	Net Income YoY
2023	$0.00	N/A	$-32563000.00	N/A
2024	$0.00	N/A	$-61922000.00	-90.2%

Revenue

Net Income

Analyst Insights

Price Targets

Average Target

$64.43

High Target

$80.00

Low Target

$45.00

Analyst Recommendations

Recommendation

Strong Buy

Analyst Coverage

7 Analysts

Upside Potential

+94.3%